Physicians' Academy for Cardiovascular Education

LMC Barcelona

Exploring the clinical value of innovations in lipid management

June 4, 2010

Master class: Exploring the clinical value of innovations in lipid management
 

Held in Barcelona, Spain in June, 2010
 
Scientific agenda

Recent insights from epidemiology: How important are lipids and apolipoproteins for prediction of future CV events?
Jane Armitage, MD, Clinical Trials Service Unit, University of Oxford, United Kingdom

Insights from clinical trials: The unassailable case for LDL-c lowering
Kausik Ray, MD University of Cambridge, United Kingdom

Residual risk: Does it exist and how do we target it?
Richard Hobbs, MD, University of Birmingham, United Kingdom

A patient with Familial Hypercholesterolemia: How to get these difficult patients to goal?
Emilio Ros, MD, Endocrinology & Nutrition Service , Hospital Clínico, Barcelona, Spain

The diabetic patient with low HDL and high Triglycerides: What are the therapeutic options?
John Betteridge, MD, University College London, United Kingdom 

A patient with a heart attack early in life:The case for very low LDL-c levels
John Deanfield, MD, University College London, United Kingdom

A patient with severe hypertriglyceridemia and acute pancreatitis: What should we do?
Erik Stroes, MD, Academic Medical Centre, Amsterdam, The Netherlands

Novel therapies for the prevention of atherosclerotic vascular disease
John Kastelein, MD, Academic Medical Centre, Amsterdam , The Netherlands
 

Insights from clinical trials:

The unassailable case for LDL-c lowering
Kausik Ray, MD
University of Cambridge
United Kingdom

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: